Journal article
Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma
PA Thompson, HM Prince, JF Seymour, D Ritchie, K Stokes, K Burbury, M Wolf, S Peinert, T Joyce, SJ Harrison
Bone Marrow Transplantation | NATURE PUBLISHING GROUP | Published : 2011
DOI: 10.1038/bmt.2010.180